THE LAUNCH
Eager to explore the vast potential of launching your product in the EU/UK? While the mission is challenging, thorough preparations can ensure a smooth route to success.
You only get one chance to launch, and studies have shown that two-thirds of launches did not reach their projected sales. If your launch is sub-optimal only a quarter of companies can get back on track, while most continue to navigate suboptimal skies.
HOW CAN YOU ENSURE LAUNCH SUCCESS?
Launching in the EU/U.K. market requires a strategic approach that encompasses these seven steps. By timing your launch correctly, navigating access processes, assembling robust clinical data, highlighting patient benefits, demonstrating economic value, establishing a pricing strategy and exploring early-access programs, you can maximize your product’s potential for success.
7. Explore early-access programs
Consider early access as part of the launch strategy as I s can help preload patient demand at launch.
6. Establish a pricing strategy.
Note that pricing processes differ across Europe and often occur post-HTA.
5. Demonstrate value in the healthcare space.
Provide health economic evidence compared to an active competitor as required in most countries.
4. Shine a light on patient benefit.
Clearly communicate the benefits your product offers to patients, improving their quality of life.
3. Build clinical strong clinical evidence.
Gather comprehensive clinical data to support the efficacy and safety of your product.
2. Navigate access processes.
Understand and comply with the regulatory requirements and market access pathways in the EU/UK.
1. Time your launch correctly.
Timing is crucial. Ensure your launch aligns with market readiness and regulatory timelines.
PARTNER WITH EXPERTS
Partnering with an expert such as EVERSANA can provide the guidance and support needed to achieve the highest revenue potential for your launch.
Click here to learn more about EVERSANA’s capabilities in the EU/UK.
Author
With more than 25 years of experience in the life sciences industry, Mike has held global leadership positions in both clinical development and life sciences software companies. Given this experience, he is highly experienced…
Monique Martin is a seasoned professional with extensive experience spanning over two decades in the pharmaceutical and healthcare industries. Before joining EVERSANA, Monique served as the Global Head of Evidence Synthesis, Modeling and Market…